Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 25-30

  Taniwaki, Masafumi ^a   Nishida, Kazuhiro ^a   Ueda, Yutaka ^a   Takashima, Teruyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Non random chromosomal rearrangements; Outcome of myeloma; Plasma cell leukemia

Indexed keywords

ALKYLATING AGENT; LACTATE DEHYDROGENASE;

ADULT; AGED; CHROMOSOME 14Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; MALE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 0030046122     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067575     Document Type: Review

References (39)

1. Rabbitts, T. H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
2. Philip, P. and Drivsholm, A. (1976) G-banding analysis of complex aneuploidy in multiple myeloma bone marrow cells. Blood, 47, 69-77.
3. Ligang, W., Hopper, J. E., and Rowley, J. D. (1979) Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer, 44, 630-644.
4. Philip, P., Drivsholm, A., Hansen, N. E., Jensen, M. K., and Killman, S. A. (1980) Chromosomes and survival in multiple myeloma. A banding study of 25 cases. Cancer Genet Cytogenet, 2, 243-257.
5. Ueshima, Y., Fukuhara, S., Nagai, K., Takatsuki, K., and Uchino, H. (1983) Cytogenetic studies and clinical aspects of patients with plasma cell leukeima and leukemic macroglobulinemia. Cancer Res, 43, 905-912.
6. Van den Berghe, Vermaelen, K., Louwagie, A., Criel, A., Mecucci, C., and Vaerraan, J. P. (1984) High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genet. Cytogenet., 11, 381-387.
7. Ferti, A., Panani, A., Arapakis, S., and Raptis, S. (1984) Cytogenetic study in multiple myeloma. Cancer Genet. Cytogenet., 12, 247-253.
8. Lewis, J. P. and Mackenzie, M. R. (1984) Non-random chromosomal aberrations associated with multiple myeloma. Hematol. Oncol., 2, 307-317.
9. Dewald, G. W., Kyle, R. A., Hicks, G. A., and Greipp, P. R. (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood, 66, 380-390.
10. Chen, K. C., Bevan, P. C., and Matthews, J. G. (1986) Analysis of G banded karyotypes in myeloma cell. J. clin. Pathol., 39, 260-266.
11. Ranni, N. S., Slavutsky, I., Wechsler, A., and Brieux, S. (1987) Chromosome finding in multiple myeloma. Cancer Genet. Cytogenet., 25, 309-316.
12. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B., and Barlogie. B. (1988) Plasma cell karyotype in multiple myeloma. Blood, 71, 453-456.
13. Nishida, K., Taniwaki, M., Misawa, S., and Abe, T. (1989) Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res., 49, 1275-1281.
14. Taniwaki, M., Nishida, K., Takashima, T., Nakagawa, H., Fujii, H., Tamaki, T., Shimazaki, C., Horiike, S., Misawa, S., Abe, T., and Kashima, K. (1994) Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood, 84, 2283-2290.
15. Van den Berghe H. (1989) Chromosomes in plasma-cell malignancies. Eur. J. Haematol. Suppl., 51 47-51.
16. Weh, H. J., Selbach, J., Fiedler, W., and Hossfeld, D. K. (1990) An identical translocation t(1;20)(q12.3;p13) in two patients with multiple myeloma. Brit. J. Haematol., 74, 365-367.
17. Nishida, K., Yashige, H., Maekawa, T., Fujii, H., Taniwaki, M., Shigeo, H., Misawa, S., Inazawa. J., and Abe, T. (1989) Chromosome rearrangement, t(6;14)(p21.1;q23.3), in multiple myeloma. Brit. J. Haematol., 71, 295-296.
18. Barlogie, B., Alexanian, R., Dixon, D., Smith, L., Smallwood, L., and Delasalle, K. (1985) Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood, 66, 338-341.
19. Clark, R. E., Geddes, A. D., Whittaker, J. A., and Jacobs, A. (1989) Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. Eur. J. Cancer Clin. Oncol., 25, 1789-1793.
20. Smith, L., Barlogie, B., and Alexanian, R. (1986) Biclonal and hypodiploid multiple myeloma. Am. J. Med., 80, 841-843.
21. Abe, T., Tsuda, S., Maekawa, T., Taniwaki, M., Sonoda, Y., Ide, T., Misawa, S., Takino, T., and Inoue, K. (1985) Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: Consideration of the harzard of drugs as possible mutagens and carcinogens causing second malignancies. Cancer Treat Report, 69, 505-514.
22. Latreille, J., Barlogie, B., Gohde, W., Johnston, D., Drewinko, B., and Alexanian, R. (1980) Cellular DNA content as a marker of human multiple myeloma. Blood, 55, 403-408.
23. Bunn, P. A., Krasnow, S., Makuch, R. W., Schlam, M., and Schechter, G. (1982) Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma. Blood, 59, 528-535.
24. Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., and Rowley, J. D. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and nonlymphocytic leukemia: Further evidence for characteristic abnormalities No. 5 and 7. J. Clin. Oncol., 4, 325-345.
25. Carroll, A. J., Crist, W. M., Parmley, R. T., Roper, M., Cooper, M. D., and Finley, W. M. (1984) Pre-B cell leukemia associated with chromosome translocation 1;19. Blood, 63, 721-724.
26. Mellentin, J. D., Murre, C., Donlon, T. A., McCaw, P. S., Smith, S. D., Carroll, A. J., McDonald, M. E., Baltimore, D., and Cleary. M. L. (1989) The gene for enhancer binding protein E12?E47 lies at the t(1; 19) breakpoint in acute leukemias. Science, 246, 379-382.
27. Kaname, T., Miyauchi, T., Kuwano, A., Matsuda, Y., Muramatsu, T., and Kajii, T. (1993) Mapping basigin (BSG), a member of the immunoglobulin superfamily, to 19p13.3. Cytogenet. Cell Genet., 64, 195-197.
28. Yamada, K., Shionoya, S., Amano, M., and Imamura, Y. (1983) A Burkitt-type 8;14 translocation in a case of plasma cell leukemia. Cancer Genet. Cytogenet., 9, 67-70.
29. Nishida, K., Taniwaki, M., Misawa, S., Abe, T., Takino, T., and Fujii, H. (1987) Translocation t(14;18) found in a patient with multiple myeloma. Cancer Genet. Cytogenet., 25, 375-377.
30. Bloomfield, C. D., Trent, J. M., and van den Berghe, H. (1987) Report of the committee on structural chromosome changes in neoplasia. Cytogenet. Cell. Genet., 46, 344-366.
31. Rowley, J. D. (1977) Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. Proc. Natl. Acad. Sci. USA, 74, 5729-5733.
32. Brito-Babapulle, V. and Atkin, N. B. (1981) Break points in chromosome # 1 abnormalities of 218 human neoplasms. Cancer Genet. Cytogenet., 4, 215-225.
33. Fukuhara, S., Kita, K., Nasu, K., Kannagi, M., Kamezaki, T., Ohono, H., Yamazawa, M., Nishigori, M., Uchino, H., Yagita, M., Matsuo, N., Yamabe, H., and Tanaka, S. (1983) Karyotype evolution in B-cell lymphoid malignancy with an 8; 14 translocation. Int. J. Cancer, 32, 555-562.
34. Heim, S. and Mitelman, F. (1986) Secondary chromosome aberrations in the acute leukemias. Cancer Genet. Cytogenet., 22, 331-338.
35. Van den Berghe, H., Louwagle, A., Broeckaert-Van Orshoven, A., David, G., Verwllghen, R., Michaux, J. L., and Sokal, G. (1979) Philadelphia chromosome in human multiple myeloma. J. Natl. Cancer Inst., 63, 11-16.
36. Karpas, A., Fisher, P., and Swirsky, D. (1982) Human myeloma cell line carrying a Philadelphia chromosome. Science, 216, 997-999.
37. Taniwaki, M., Matsuda, F., Jauch, A., Nishida, K., Takashima, T., Tagawa, S., Sugiyama, H., Misawa, S., Abe, T., and Kashima, K. (1994) Detection of 14q32 translocation in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus. Blood, 83, 2962-2969.
38. Taniwaki, M., Nishida, K., Ueda, Y., Misawa, S., Nagai, M., Tagawa, S., Yamagami, T., Sugiyama, H., Abe, M., Fukuhara, S., Kashima, K. (1995) Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell maliganancies by double-color fluorescence in situ hybridization. Blood 85, 3223-3228.
39. Barlogie, B., Epstein, J., Selvanayagan, P., and Alexanian, R. (1989) Plasma cell myeloma-new biological insights and advances in therapy. Blood, 73, 865-879.